Diabetic macular edema: it is more than just VEGF [version 1; referees: 2 approved]
Michael A. Singer, Daniel S. Kermany, Jana Waters and 2 more
F1000Research · 2016
doi:10.12688/f1000research.8265.1 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Diabetic macular edema is a serious visual complication of diabetic retinopathy. This article reviews the history of previous and current therapies, including laser therapy, anti-vascular endothelial growth factor agents, and corticosteroids, that have been used to treat this condition. In addition, it proposes new ways to use them in combination in order to decrease treatment burden and potentially address other causes besides vascular endothelial growth factor for diabetic macular edema.
Abstract licence: CC BY
Cited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.